Case Report: Primary Squamous Cell Carcinoma of Kidney-An Unusual Malignancy
- Authors
-
-
Abdul Rashid Lone
Medical Oncology, Sheri Kashmir Institute of Medical Sciences, Srinagar-190011, India -
Shiekh Aejaz Aziz
Medical Oncology, Sheri Kashmir Institute of Medical Sciences, Srinagar-190011, India -
Mohmad Hussain Mir
Medical Oncology, Sheri Kashmir Institute of Medical Sciences, Srinagar-190011, India -
Sumyra K. Qadri
Medical Oncology, Sheri Kashmir Institute of Medical Sciences, Srinagar-190011, India -
Arif N. Bhat
Medical Oncology, Sheri Kashmir Institute of Medical Sciences, Srinagar-190011, India -
Farhana S. Bagdadi
Medical Oncology, Sheri Kashmir Institute of Medical Sciences, Srinagar-190011, India -
Syed Nisar
Medical Oncology, Sheri Kashmir Institute of Medical Sciences, Srinagar-190011, India -
Ulfat Ara
Medical Oncology, Sheri Kashmir Institute of Medical Sciences, Srinagar-190011, India
-
- Keywords:
- Kidney, Squamous Cell Carcinoma, Renal Calculi, Renal squamous cell carcinoma, Urothelial tumours.
- Abstract
-
Primary Squamous Cell Carcinoma of the kidney is a rare clinical entity involving the upper urinary tract.These patients characteristically presents in advanced stage. This rare malignancy of the kidney lacks the characteristic clinical presentation of common renal cell carcinoma like hematuria, pain and a palpable mass. We report a 60 year old male who presented with a history of recurrent colicky right flank pain for 6 months duration which worsened in intensity and increased in frequency from last 1 month. He also had a history of untreated right renal calcular disease. On evaluation, he was found to have right renal mass with CT guided biopsy revealing Squamous cell carcinoma of kidney.
- Downloads
-
Download data is not yet available.
- References
-
Murphy DM, Zincke H, Furlow WL. Primary grade I transitional cell carcinoma of the renal pelvis and ureter. J Urol 1980; 123: 629-31.
Latham HS, Kay S. Malignant tumors of the renal pelvis. Surg Gynecol Obstet 1974; 138: 613-22.
Utz DC, Mc Donalt JR. Squamous cell carcinoma of the kidney. J Urol 1957; 78: 540-52.
Li MK, Cheung WL. Squamous cell carcinoma of the kindey. J Urol 1987; 138: 269-71.
Blacher EJ, Johnson DE, Abdul-Karim FW, et al. Squamous cell carcinoma of renal pelvis. Urology 1985; 25: 124-6.
Karabulut A, Emir L, Gonultas NI, et al. Squamous cell carcinoma located in the renal caliceal system: A case report and review of the literature. Turkish J Cancer 2002; 32(1): 20-4.
Odabas O, Karakok M, Yilmaz Y, et al. Squamaous cell carcinoma of kidney. Eastren J Med 2000; 5(1): 35-6.
Busby JE, Brown GA, Tamboli P, et al. Upper urinary tract tumors with non transitional histology: a single-center experience. Urology 2006; 67(3): 518-23.
Er O, Coskun HS, Altinbas M, et al. Rapidly relapsing squamous cell carcinoma of the renal pelvis associated with paraneoplastic syndromes of leukocytosis, thrombocytosis and hypercalcemia. Urol Int 2001; 67(2): 175-7.
Corral DA, Sella A, Pettaway CA, et al. combination chemotherapy for metastatic of locally advanced genitourinary squamous cell carcinoma: A phase II study of methotrexate, cisplatin and bleomycin. J Urol 1998; 160: 1770-4.
Lee TY, Ko JF, Wan YL, et al. Renal squamous cell carcinoma: CT findings and clinical significance. Abdom Imaging 1998; 23: 203-8.
Nativ O, Reiman HM, Lieber MM, et al. Treatment of primary squamous cell carcinoma of the upper urinary tract. Cancer 1991; 68: 2575-8.
- Downloads
- Published
- 28-09-2013
- Issue
- Vol. 2 No. 3 (2013)
- Section
- Articles
How to Cite
Similar Articles
- Chiranjeev Singh, Prachi Gurudiwan, Nanoparticle-Based Drug Delivery Systems for Tumor Treatment: Advancing Solutions to Overcome Drug Resistance , Journal of Cancer Research Updates: Vol. 14 (2025)
- Abdul Lateef Ali Asghar, Anas K. Awn, Ban Hussein Ali, Nawras Khairi Fadhil, Youssef Shakuri Yasin, Assessing the Role of Bi- and Multi-Parametric MRI in Prostate Cancer-A Regional Study , Journal of Cancer Research Updates: Vol. 14 (2025)
- Nikhil Vasdev, Patricia McClurey, Debra Gray, Aftab Bhatti, David Chadwick, An Audit to Evaluate the Clinical Safety and PSA Response of Firmagon® (Degarelix) in Patients with Advanced Metastatic Prostate Cancer - , Journal of Cancer Research Updates: Vol. 2 No. 1 (2013)
- R. Hsieh, M.L. Prasad, M.M.S. Nico, H. Tavares, A. Altemani, R.S.S. Macarenco, S.V. Lourenço, A Study of C-MYC, SOX10 and BCL-2 Proteins Expression in Head and Neck Mucosal Melanomas , Journal of Cancer Research Updates: Vol. 5 No. 4 (2016)
- Cord Naujokata, Stefan Laufer, Targeting Cancer Stem Cells with Defined Compounds and Drugs , Journal of Cancer Research Updates: Vol. 2 No. 1 (2013)
- Shashi K. Agarwal, Exercise: Preventive and Therapeutic Benefits in Cancer , Journal of Cancer Research Updates: Vol. 10 (2021)
- Kang-Yao Zeng, Qing-Yi Zhou, Yun-Xi Zhang, Zhe-Sheng Chen, Zhi Shi, Song-Wang Cai, Apoptozole Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer , Journal of Cancer Research Updates: Vol. 14 (2025)
- Masao Takatori, Makoto Yagi, Sadao Hattori, Potential Solutions in Radiation Hormesis , Journal of Cancer Research Updates: Vol. 2 No. 2 (2013)
- Kenji Ina, Mikinori Miyazaki, Tomoko Nishio, Yuko Kato, Satoshi Kayukawa, Takae Kataoka, Katsuhiko Endo, Tomoki Fukuoka, Metachronous Breast and Lung Cancers in a Middle-Aged Woman with Peutz-Jeghers Syndrome , Journal of Cancer Research Updates: Vol. 13 (2024)
- Saurabh G. Vispute, Jun-Jiang Chen, Yue-Li Sun, Kamlesh S. Sodani, Satyakam Singh, Yihang Pan, Tanaji Talele, Charles R. Ashby Jr, Zhe-Sheng Chen, Vemurafenib (PLX4032, Zelboraf®), a BRAF Inhibitor, Modulates ABCB1-, ABCG2-, and ABCC10-Mediated Multidrug Resistance , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
You may also start an advanced similarity search for this article.